These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 19176987)

  • 21. Pathophysiological actions of protease activated receptors (PARs).
    Pandya NM; Jain SM; Santani DD
    Pharmazie; 2007 Mar; 62(3):163-9. PubMed ID: 17416190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Thrombin induced tumour growth - pharmacological control].
    Nowak G; Lopez M; Zieger M
    Hamostaseologie; 2007 May; 27(2):105-10. PubMed ID: 17479173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of protease-activated receptors in astrocytes evokes a novel neuroprotective pathway through release of chemokines of the growth-regulated oncogene/cytokine-induced neutrophil chemoattractant family.
    Wang Y; Luo W; Reiser G
    Eur J Neurosci; 2007 Dec; 26(11):3159-68. PubMed ID: 18005059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer resistance in transgenic mice expressing the SAC module of Par-4.
    Zhao Y; Burikhanov R; Qiu S; Lele SM; Jennings CD; Bondada S; Spear B; Rangnekar VM
    Cancer Res; 2007 Oct; 67(19):9276-85. PubMed ID: 17909035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombin generation and the pathogenesis of cancer.
    Ruf W; Mueller BM
    Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():61-8. PubMed ID: 16673267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extracellular mediators in atherosclerosis and thrombosis: lessons from thrombin receptor knockout mice.
    Major CD; Santulli RJ; Derian CK; Andrade-Gordon P
    Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):931-9. PubMed ID: 12676802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protease-activated receptors in neuronal development, neurodegeneration, and neuroprotection: thrombin as signaling molecule in the brain.
    Rohatgi T; Sedehizade F; Reymann KG; Reiser G
    Neuroscientist; 2004 Dec; 10(6):501-12. PubMed ID: 15534036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The biological role of protease-activated receptors in angiology. The present view.
    Skórkowska K; Adamiec R
    Int Angiol; 2005 Sep; 24(3):215-20. PubMed ID: 16158029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protease-activated receptors: protease signaling in the gastrointestinal tract.
    Amadesi S; Bunnett N
    Curr Opin Pharmacol; 2004 Dec; 4(6):551-6. PubMed ID: 15525542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity.
    Shpacovitch V; Feld M; Hollenberg MD; Luger TA; Steinhoff M
    J Leukoc Biol; 2008 Jun; 83(6):1309-22. PubMed ID: 18347074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protease-activated receptors: how proteases signal to cells to cause inflammation and pain.
    Bunnett NW
    Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():39-48. PubMed ID: 16673265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular protease receptors: integrating haemostasis and endothelial cell functions.
    Preissner KT; Nawroth PP; Kanse SM
    J Pathol; 2000 Feb; 190(3):360-72. PubMed ID: 10685070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The roles of proteinase-activated receptors in the vascular physiology and pathophysiology.
    Hirano K
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):27-36. PubMed ID: 17095716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coagulation factor Xa signaling: the link between coagulation and inflammatory bowel disease?
    Borensztajn K; Peppelenbosch MP; Spek CA
    Trends Pharmacol Sci; 2009 Jan; 30(1):8-16. PubMed ID: 19058861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteinase-activated receptor pharmacology: trickier and trickier.
    Moffatt JD
    Br J Pharmacol; 2004 Oct; 143(4):441. PubMed ID: 15381632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coagulation signalling following tissue injury: focus on the role of factor Xa.
    Krupiczojc MA; Scotton CJ; Chambers RC
    Int J Biochem Cell Biol; 2008; 40(6-7):1228-37. PubMed ID: 18420447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protease-activated receptors in the musculoskeletal system.
    Mackie EJ; Loh LH; Sivagurunathan S; Uaesoontrachoon K; Yoo HJ; Wong D; Georgy SR; Pagel CN
    Int J Biochem Cell Biol; 2008; 40(6-7):1169-84. PubMed ID: 18243039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shooting for PARs in lung diseases.
    Moffatt JD; Page CP; Laurent GJ
    Curr Opin Pharmacol; 2004 Jun; 4(3):221-9. PubMed ID: 15140412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The calcium-binding domain of the stress protein SEP53 is required for survival in response to deoxycholic acid-mediated injury.
    Darragh J; Hunter M; Pohler E; Nelson L; Dillon JF; Nenutil R; Vojtesek B; Ross PE; Kernohan N; Hupp TR
    FEBS J; 2006 May; 273(9):1930-47. PubMed ID: 16640557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel therapeutic target in various lung diseases: airway proteases and protease-activated receptors.
    Sokolova E; Reiser G
    Pharmacol Ther; 2007 Jul; 115(1):70-83. PubMed ID: 17532472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.